(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1637686

北米の放射線腫瘍学市場：2031年までの予測 - 地域別分析 - タイプ別、用途別

North America Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application
PrevNext
1
2
3
4

出版日
ページ情報
英文 80 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
北米の放射線腫瘍学市場：2031年までの予測 - 地域別分析 - タイプ別、用途別
出版日: 2024年11月22日
発行: The Insight Partners
ページ情報: 英文 80 Pages
納期: 即納可能 即納可能とは
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の放射線腫瘍学市場は、2023年に40億4,723万米ドルとなり、2031年までには104億958万米ドルに達すると予測され、2023年から2031年までのCAGRは12.5%を記録すると予測されています。

がんの有病率の増加が北米の放射線腫瘍学市場を後押し

がんは、世界中の社会に大きな影響を与えている一般的な健康状態の1つです。世界保健機関（WHO）によると、がんは世界の主要な死因であり、2023年には970万人が死亡、2,000万人が新たにがんに罹患し、2050年には3,500万人に達すると予測されています。WHOの2024年報告書によると、肺がんは最も一般的ながんであり、世界の死亡原因のトップです。次いで大腸がん、肝臓がん、乳がん、胃がんで、それぞれ死亡者全体の18.7％、9.3％、7.8％、6.9％、6.8％を占めます。

がんの有病率と罹患率の増加は、効果的な治療オプションに対する需要を生み出しています。放射線治療は、がん細胞を死滅させるためにX線、ガンマ線などの高線量放射線を利用する、がん患者のための効果的な結果をもたらす発展的な治療オプションの1つです。放射線治療はがんの初期段階で使用され、様々な種類の外部照射放射線治療が様々ながんの治療に使用されています。例えば、ブラキセラピーは乳がん、子宮頸がん、眼がん、前立腺がん、頭頸部がんの治療に用いられます。同様に、全身放射線療法は放射性ヨードとしても知られ、甲状腺がんの治療に用いられます。放射線療法は治療のどの時点でも使用でき、手術、化学療法、免疫療法などの他の治療と組み合わせることもできます。したがって、がんの有病率の増加と腫瘍学における放射線治療の進化が、放射線腫瘍学市場の成長を促進すると予想されます。

北米の放射線腫瘍学市場の概要

米国では、すべてのがん患者に対して放射線療法が広く行われており、放射線腫瘍医のニーズは増加の一途をたどっています。このような専門家の数も、開発されたヘルスケアインフラのおかげで継続的に増加しています。とはいえ、米国臨床腫瘍学会（American Society of Clinical Oncology）によれば、世界のがん患者の約3分の2は治療の一環として放射線療法を受けていると推定されています。2023年には、米国で年間100万人以上のがん患者が放射線療法を受けると予測されています。政府やヘルスケア当局は、放射線治療の導入を促進するためにいくつかのイニシアチブをとっています。2020年6月、米国放射線腫瘍学会（ASTRO）は、非転移性子宮頸がんに対する放射線療法に関する新しい臨床ガイドラインを発表しました。新ガイドラインは、放射線療法を実施するための手順やプロセスを正確に実施することに重点を置いています。

北米の放射線腫瘍学市場の収益と2031年までの予測（金額）

北米の放射線腫瘍学市場のセグメンテーション

北米の放射線腫瘍学市場は、タイプ、用途、国に分類されます。

タイプ別に見ると、北米の放射線腫瘍学市場は外照射療法と内照射療法に二分されます。2023年の市場シェアは、外照射療法分野が大きいです。

用途別では、北米の放射線腫瘍学市場は乳がん、前立腺がん、肺がん、頭頸部がん、子宮頸がん、その他に分類されます。2023年には乳がん分野が最大の市場シェアを占めました。

国別では、北米の放射線腫瘍学市場は米国、カナダ、メキシコに区分されます。2023年の北米の放射線腫瘍学市場シェアは米国が独占しました。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide（Ion Beam Applications SA）、Becton Dickinson and Co、Perspective Therapeutics Inc、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcare、Curiumは、北米の放射線腫瘍学市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 北米の放射線腫瘍学市場情勢

  • PEST分析

第5章 北米の放射線腫瘍学市場：主要市場力学

  • 市場促進要因
    • がんの有病率の増加
    • 放射線腫瘍学の開発を支援する取り組み
  • 市場抑制要因
    • 放射線治療機器の高コスト
  • 市場機会
    • 放射線腫瘍学における戦略的イニシアティブ
  • 今後の動向
    • 放射線腫瘍学の技術進歩
  • 促進要因と抑制要因の影響

第6章 放射線腫瘍学市場：北米市場分析

  • 放射線腫瘍学市場の収益、2021年～2031年

第7章 北米の放射線腫瘍学市場分析：タイプ別

  • 外部ビーム放射線療法
  • 内部ビーム放射線療法

第8章 北米の放射線腫瘍学市場分析：用途別

  • 乳がん
  • 前立腺がん
  • 肺がん
  • 頭頸部がん
  • 子宮頸がん
  • その他

第9章 北米の放射線腫瘍学市場：国別分析

    • 北米
      • 米国
      • カナダ
      • メキシコ

第10章 放射線腫瘍学市場：業界情勢

  • 放射線腫瘍学市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第11章 企業プロファイル

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide（Ion Beam Applications SA）
  • Becton Dickinson and Co
  • Perspective Therapeutics Inc
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Provision Healthcare
  • Curium

第12章 付録

図表

List Of Tables

  • Table 1. North America Radiation Oncology Market Segmentation
  • Table 2. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 15. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 16. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. North America Radiation Oncology Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Radiation Oncology Market - Key Market Dynamics
  • Figure 4. Statistics at Glance, Global, 2022
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 7. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 8. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 11. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. North America Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 18. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 19. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Growth Strategies in Radiation Oncology Market
目次
Product Code: BMIRE00031021

The North America radiation oncology market was valued at US$ 4,047.23 million in 2023 and is expected to reach US$ 10,409.58 million by 2031; it is estimated to record a CAGR of 12.5% from 2023 to 2031.

Increasing Prevalence of Cancer Fuels North America Radiation Oncology Market

Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2023 and it is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer and leading cause of the death globally followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer accounting for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total deaths respectively.

The increasing prevalence and incidence of cancer creates demand for effective treatment options. Radiotherapy is one of evolving treatment options for cancer patients with effective outcome which utilizes the high doses of radiation such as X-rays, gamma rays, and others to kill the cancerous cells. Radiotherapy is used in the early stages of cancer and various types of external beam radiotherapy are used for the treatment of different cancers. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Similarly, Systemic radiation therapy is also known as radioactive iodine and is used for treatment of thyroid cancer. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others. Therefore, increasing prevalence of cancer and evolution of radiotherapy in oncology is expected to drive the growth of radiation oncology market.

North America Radiation Oncology Market Overview

Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2023, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy.

North America Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

North America Radiation Oncology Market Segmentation

The North America radiation oncology market is categorized into types, application, and country.

Based on types, the North America radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the North America radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the North America radiation oncology market is segmented into the US, Canada, and Mexico. The US dominated the North America radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, and Curium are some of the leading companies operating in the North America radiation oncology market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Radiation Oncology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Radiation Oncology Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Increasing Prevalence of Cancer
    • 5.1.2 Initiatives to Support Developments in Radiation Oncology
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Radiotherapy Equipment
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives in Radiation Oncology
  • 5.4 Future Trends
    • 5.4.1 Technological Advancement in Radiation Oncology
  • 5.5 Impact of Drivers and Restraints:

6. Radiation Oncology Market - North America Market Analysis

  • 6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. North America Radiation Oncology Market Analysis - by Types

  • 7.1 External Beam Radiation Therapy
    • 7.1.1 Overview
    • 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Internal Beam Radiation Therapy
    • 7.2.1 Overview
    • 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Radiation Oncology Market Analysis - by Application

  • 8.1 Breast Cancer
    • 8.1.1 Overview
    • 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Prostate Cancer
    • 8.2.1 Overview
    • 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lung Cancer
    • 8.3.1 Overview
    • 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Head and Neck Cancer
    • 8.4.1 Overview
    • 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Cervical Cancer
    • 8.5.1 Overview
    • 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Radiation Oncology Market - Country Analysis

  • 9.1 North America Radiation Oncology Market Overview
    • 9.1.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.1 United States: Radiation Oncology Market Breakdown, by Types
        • 9.1.1.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.1.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.1.1.4 United States: Radiation Oncology Market Breakdown, by Application
      • 9.1.1.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 Canada: Radiation Oncology Market Breakdown, by Types
        • 9.1.1.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.1.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.1.2.4 Canada: Radiation Oncology Market Breakdown, by Application
      • 9.1.1.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
        • 9.1.1.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.1.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.1.3.4 Mexico: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Radiation Oncology Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Varian Medical Systems Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elekta AB
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Accuray Incorporated
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 IBA Worldwide (Ion Beam Applications SA)
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Becton Dickinson and Co
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Perspective Therapeutics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 NTP RADIOISOTOPES
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Mallinckrodt Plc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Provision Healthcare
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Curium
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms